Jones, M L

RGD-ligand mimetic antagonists of integrin alphaIIbbeta3 paradoxically enhance GPVI-induced human platelet activation. [electronic resource] - Journal of thrombosis and haemostasis : JTH Mar 2010 - 567-76 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1538-7836

10.1111/j.1538-7836.2009.03719.x doi


Benzodiazepines--pharmacology
Biomimetics
Blood Coagulation--drug effects
Blood Platelets--drug effects
Calcium Signaling--drug effects
Enzyme Activation
Humans
Immunoglobulin gamma-Chains--blood
Intracellular Signaling Peptides and Proteins--blood
Ligands
Oligopeptides--blood
Phosphatidylserines--blood
Phosphorylation
Piperidines--pharmacology
Platelet Activation--drug effects
Platelet Aggregation Inhibitors--adverse effects
Platelet Glycoprotein GPIIb-IIIa Complex--antagonists & inhibitors
Platelet Membrane Glycoproteins--metabolism
Protein Conformation
Protein-Tyrosine Kinases--blood
Purinergic P2 Receptor Antagonists
Receptors, Purinergic P2--blood
Receptors, Purinergic P2Y12
Secretory Vesicles--drug effects
Syk Kinase
Time Factors
Tirofiban
Tyrosine--analogs & derivatives
src-Family Kinases--blood